Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

Europe - BIT:CRL - IT0005331019 - Common Stock

22.9 EUR
-0.05 (-0.22%)
Last: 9/17/2025, 2:32:15 PM
Fundamental Rating

5

Overall CRL gets a fundamental rating of 5 out of 10. We evaluated CRL against 19 industry peers in the Building Products industry. Both the health and profitability get an excellent rating, making CRL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, CRL is valued expensive at the moment. With these ratings, CRL could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRL was profitable.
CRL had a positive operating cash flow in the past year.
CRL had positive earnings in each of the past 5 years.
Each year in the past 5 years CRL had a positive operating cash flow.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

With an excellent Return On Assets value of 7.29%, CRL belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
The Return On Equity of CRL (14.29%) is better than 78.95% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.69%, CRL is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRL is above the industry average of 9.60%.
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROIC 8.69%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CRL has a better Profit Margin (10.34%) than 89.47% of its industry peers.
In the last couple of years the Profit Margin of CRL has remained more or less at the same level.
CRL has a Operating Margin of 11.63%. This is amongst the best in the industry. CRL outperforms 89.47% of its industry peers.
In the last couple of years the Operating Margin of CRL has declined.
CRL has a Gross Margin (45.73%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CRL has grown nicely.
Industry RankSector Rank
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

CRL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRL has about the same amount of shares outstanding.
The number of shares outstanding for CRL has been increased compared to 5 years ago.
Compared to 1 year ago, CRL has an improved debt to assets ratio.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CRL has an Altman-Z score of 5.63. This indicates that CRL is financially healthy and has little risk of bankruptcy at the moment.
CRL has a Altman-Z score of 5.63. This is amongst the best in the industry. CRL outperforms 89.47% of its industry peers.
CRL has a debt to FCF ratio of 1.66. This is a very positive value and a sign of high solvency as it would only need 1.66 years to pay back of all of its debts.
CRL has a Debt to FCF ratio of 1.66. This is amongst the best in the industry. CRL outperforms 94.74% of its industry peers.
CRL has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, CRL is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Altman-Z 5.63
ROIC/WACC1.12
WACC7.75%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

CRL has a Current Ratio of 1.58. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
CRL has a Current ratio (1.58) which is comparable to the rest of the industry.
A Quick Ratio of 1.13 indicates that CRL should not have too much problems paying its short term obligations.
CRL has a better Quick ratio (1.13) than 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.13
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CRL have decreased strongly by -19.15% in the last year.
CRL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.70% yearly.
Looking at the last year, CRL shows a decrease in Revenue. The Revenue has decreased by -2.99% in the last year.
Measured over the past years, CRL shows a quite strong growth in Revenue. The Revenue has been growing by 12.06% on average per year.
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%

3.2 Future

The Earnings Per Share is expected to grow by 10.25% on average over the next years. This is quite good.
Based on estimates for the next years, CRL will show a quite strong growth in Revenue. The Revenue will grow by 8.47% on average per year.
EPS Next Y-2.75%
EPS Next 2Y7.61%
EPS Next 3Y10.25%
EPS Next 5YN/A
Revenue Next Year7.79%
Revenue Next 2Y8.61%
Revenue Next 3Y8.47%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.89 indicates a quite expensive valuation of CRL.
CRL's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.20, CRL is valued quite expensively.
A Price/Forward Earnings ratio of 35.32 indicates a quite expensive valuation of CRL.
CRL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CRL is more expensive than 68.42% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, CRL is valued quite expensively.
Industry RankSector Rank
PE 40.89
Fwd PE 35.32
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

84.21% of the companies in the same industry are cheaper than CRL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29.7
EV/EBITDA 23.85
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CRL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.21
EPS Next 2Y7.61%
EPS Next 3Y10.25%

3

5. Dividend

5.1 Amount

CRL has a yearly dividend return of 0.72%, which is pretty low.
CRL's Dividend Yield is slightly below the industry average, which is at 3.97.
Compared to an average S&P500 Dividend Yield of 2.38, CRL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.72%

5.2 History

On average, the dividend of CRL grows each year by 14.04%, which is quite nice.
Dividend Growth(5Y)14.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

30.38% of the earnings are spent on dividend by CRL. This is a low number and sustainable payout ratio.
CRL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.38%
EPS Next 2Y7.61%
EPS Next 3Y10.25%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (9/17/2025, 2:32:15 PM)

22.9

-0.05 (-0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-01 2025-08-01
Earnings (Next)11-13 2025-11-13
Inst Owners28.06%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.58B
Analysts72
Price Target23.39 (2.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.72%
Yearly Dividend0.19
Dividend Growth(5Y)14.04%
DP30.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.67%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-3.4%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-1.82%
Revenue beat(8)2
Avg Revenue beat(8)-2.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.3%
PT rev (3m)15.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-0.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.66%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 40.89
Fwd PE 35.32
P/S 4.34
P/FCF 29.7
P/OCF 22.56
P/B 6
P/tB 43.71
EV/EBITDA 23.85
EPS(TTM)0.56
EY2.45%
EPS(NY)0.65
Fwd EY2.83%
FCF(TTM)0.77
FCFY3.37%
OCF(TTM)1.01
OCFY4.43%
SpS5.27
BVpS3.81
TBVpS0.52
PEG (NY)N/A
PEG (5Y)4.21
Profitability
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROCE 10.92%
ROIC 8.69%
ROICexc 10.39%
ROICexgc 34.66%
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
FCFM 14.62%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
ROICexc(3y)15.05%
ROICexc(5y)17.4%
ROICexgc(3y)43.53%
ROICexgc(5y)43.91%
ROCE(3y)14.8%
ROCE(5y)15.83%
ROICexcg growth 3Y-17.51%
ROICexcg growth 5Y-0.61%
ROICexc growth 3Y-24.29%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Debt/EBITDA 0.83
Cap/Depr 66.97%
Cap/Sales 4.62%
Interest Coverage 15.41
Cash Conversion 103.86%
Profit Quality 141.48%
Current Ratio 1.58
Quick Ratio 1.13
Altman-Z 5.63
F-Score6
WACC7.75%
ROIC/WACC1.12
Cap/Depr(3y)91.98%
Cap/Depr(5y)87.52%
Cap/Sales(3y)4.87%
Cap/Sales(5y)4.61%
Profit Quality(3y)86.55%
Profit Quality(5y)91.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
EPS Next Y-2.75%
EPS Next 2Y7.61%
EPS Next 3Y10.25%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%
Revenue Next Year7.79%
Revenue Next 2Y8.61%
Revenue Next 3Y8.47%
Revenue Next 5YN/A
EBIT growth 1Y-15.06%
EBIT growth 3Y1.26%
EBIT growth 5Y7.88%
EBIT Next Year83.59%
EBIT Next 3Y32.38%
EBIT Next 5YN/A
FCF growth 1Y46.46%
FCF growth 3Y14.88%
FCF growth 5Y15.64%
OCF growth 1Y34.27%
OCF growth 3Y16.42%
OCF growth 5Y11.49%